Literature DB >> 10953314

Effects of quercetin on the cell growth and the intracellular accumulation and retention of adriamycin.

J Asaum1, H Matsuzaki, S Kawasak, M Kuroda, Y Takeda, K Kishi, Y Hiraki.   

Abstract

In this study, we examined the inhibitory effects on cell growth and the effects of quercetin on intracellular accumulation of adriamycin (ADR) in wild type Ehrlich ascites tumor cells (wild EAT cells) and their ADR-resistant strain. Quercetin strongly inhibited growth in both strains. Cell growth reached a plateau at 3.5 days in the wild type EAT cells and at 7 days in the ADR-resistant strain. The inhibitory concentration in 50% of the ADR-resistant cells on day 7 (24 microM) was twice that of the wild type EAT cells on day 4 (12 microM) after continuous treatment with quercetin. Quercetin decreased the ADR accumulation in the wild type cells but did not affect it in the ADR-resistant cells. Further, quercetin did not affect the retention of ADR in either strain. These results indicated that quercetin decreased ADR accumulation without extruding ADR in the wild type EAT cells. ADR accumulation in the ADR-resistant cells treated with quercetin for 7 days was increased with increasing concentrations of quercetin. Moreover, ADR accumulation in the ADR-resistant cells treated with 50 microM quercetin for 7 days, increased to 186.6% and to 181.9% of that in untreated cells after 60 minutes and 120 minutes incubation, respectively, whilst it increased to 70% from 37.5% of that in the wild type EAT cells after 60 minutes incubation. These findings indicated that quercetin might reverse ADR-resistance.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10953314

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  9 in total

Review 1.  Effects of food on the clinical pharmacokinetics of anticancer agents: underlying mechanisms and implications for oral chemotherapy.

Authors:  Brahma N Singh; Bimal K Malhotra
Journal:  Clin Pharmacokinet       Date:  2004       Impact factor: 6.447

Review 2.  Heat shock proteins 27, 40, and 70 as combinational and dual therapeutic cancer targets.

Authors:  Jeanette R McConnell; Shelli R McAlpine
Journal:  Bioorg Med Chem Lett       Date:  2013-02-13       Impact factor: 2.823

3.  Synergetic anticancer effect of combined quercetin and recombinant adenoviral vector expressing human wild-type p53, GM-CSF and B7-1 genes on hepatocellular carcinoma cells in vitro.

Authors:  Ming Shi; Fu-Sheng Wang; Zu-Ze Wu
Journal:  World J Gastroenterol       Date:  2003-01       Impact factor: 5.742

4.  Enhancing oral bioavailability of quercetin using novel soluplus polymeric micelles.

Authors:  Linghui Dian; Enjiang Yu; Xiaona Chen; Xinguo Wen; Zhengzan Zhang; Lingzhen Qin; Qingqing Wang; Ge Li; Chuanbin Wu
Journal:  Nanoscale Res Lett       Date:  2014-12-18       Impact factor: 4.703

5.  Structural insights into the polypharmacological activity of quercetin on serine/threonine kinases.

Authors:  Bincy Baby; Priya Antony; Walaa Al Halabi; Zahrah Al Homedi; Ranjit Vijayan
Journal:  Drug Des Devel Ther       Date:  2016-09-27       Impact factor: 4.162

Review 6.  Targeting Heat Shock Proteins in Cancer: A Promising Therapeutic Approach.

Authors:  Suman Chatterjee; Timothy F Burns
Journal:  Int J Mol Sci       Date:  2017-09-15       Impact factor: 5.923

Review 7.  Targeting Heat Shock Protein 27 in Cancer: A Druggable Target for Cancer Treatment?

Authors:  Seul-Ki Choi; Heejin Kam; Kye-Young Kim; Suk In Park; Yun-Sil Lee
Journal:  Cancers (Basel)       Date:  2019-08-16       Impact factor: 6.639

8.  Characterization of the dual functional effects of heat shock proteins (HSPs) in cancer hallmarks to aid development of HSP inhibitors.

Authors:  Zhao Zhang; Ji Jing; Youqiong Ye; Zhiao Chen; Ying Jing; Shengli Li; Wei Hong; Hang Ruan; Yaoming Liu; Qingsong Hu; Jun Wang; Wenbo Li; Chunru Lin; Lixia Diao; Yubin Zhou; Leng Han
Journal:  Genome Med       Date:  2020-11-23       Impact factor: 11.117

Review 9.  Heat Shock Proteins in Cancer Immunotherapy.

Authors:  Jugal Kishore Das; Xiaofang Xiong; Xingcong Ren; Jin-Ming Yang; Jianxun Song
Journal:  J Oncol       Date:  2019-12-11       Impact factor: 4.375

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.